Table 2.

Association between baseline and second sample (after first treatment cycle).

	ABI cohort		DOC cohort
	Second sample		Second sample
	z-score	p-value	z-score	p-value
miR-93-5p	−0.680	0.496	−2.255	0.024
miR-125b-1-5p	−0.045	0.963	−0.399	0.690
miR-141-3p	−1.247	0.212	−3.870	<0.001
miR-221-3p	−1.962	0.049	−2.168	0.030
miR-375-3p	−0.505	0.613	−4.148	<0.001

ABI: abiraterone; DOC: docetaxel. Statistically significant values are in bold writing.